These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Vaccination against papillomavirus in cattle. Campo MS Clin Dermatol; 1997; 15(2):275-83. PubMed ID: 9167911 [No Abstract] [Full Text] [Related]
5. Papillomaviruses: progress for human and veterinary medicine. Onions D Vet J; 1997 Nov; 154(3):171-2. PubMed ID: 9414949 [No Abstract] [Full Text] [Related]
6. Vaccination against papillomavirus in cattle. Campo MS Curr Top Microbiol Immunol; 1994; 186():255-66. PubMed ID: 8205844 [No Abstract] [Full Text] [Related]
7. Adventitious pestivirus RNA in live virus vaccines against bovine and swine diseases. Harasawa R Vaccine; 1995 Jan; 13(1):100-3. PubMed ID: 7762264 [TBL] [Abstract][Full Text] [Related]
8. Vaccination against cutaneous and mucosal papillomavirus in cattle. Campo MS; Jarrett WF Ciba Found Symp; 1994; 187():61-73; discussion 73-7. PubMed ID: 7796677 [TBL] [Abstract][Full Text] [Related]
9. Vaccination against herpesvirus, fiction or reality? Morein B; Merza M Scand J Infect Dis Suppl; 1991; 80():110-8. PubMed ID: 1666442 [TBL] [Abstract][Full Text] [Related]
10. Restoration of thymidine kinase activity in a potential bovine herpesvirus 2 vaccine does not increase its virulence. Paxman JJ; Enriquez AM; May JT Acta Virol; 2000 Feb; 44(1):57-9. PubMed ID: 10989694 [No Abstract] [Full Text] [Related]
12. Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice. Cremer KJ; Mackett M; Wohlenberg C; Notkins AL; Moss B Science; 1985 May; 228(4700):737-40. PubMed ID: 2986288 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic value of partial excision of lesions combined with administration of an autogenous vaccine during an episode of cutaneous papillomatosis in cattle of Uganda. Ssenyonga GS; Onapito JS; Nakasala-Situma J; Omara-Opyene AL J Am Vet Med Assoc; 1990 Sep; 197(6):739-40. PubMed ID: 2170314 [TBL] [Abstract][Full Text] [Related]
14. Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization. Kirnbauer R; Chandrachud LM; O'Neil BW; Wagner ER; Grindlay GJ; Armstrong A; McGarvie GM; Schiller JT; Lowy DR; Campo MS Virology; 1996 May; 219(1):37-44. PubMed ID: 8623552 [TBL] [Abstract][Full Text] [Related]
15. Recombinant interleukin 2 as an adjuvant for vaccine-induced protection. Immunization of guinea pigs with herpes simplex virus subunit vaccines. Weinberg A; Merigan TC J Immunol; 1988 Jan; 140(1):294-9. PubMed ID: 2826591 [TBL] [Abstract][Full Text] [Related]
16. Prophylactic and therapeutic vaccination against a mucosal papillomavirus. Campo MS; Grindlay GJ; O'Neil BW; Chandrachud LM; McGarvie GM; Jarrett WF J Gen Virol; 1993 Jun; 74 ( Pt 6)():945-53. PubMed ID: 8389809 [TBL] [Abstract][Full Text] [Related]
17. [Herpes simplex virus vaccine studies: from past to present]. Us D Mikrobiyol Bul; 2006 Oct; 40(4):413-33. PubMed ID: 17205702 [TBL] [Abstract][Full Text] [Related]
18. Recombinant DNA technology for the preparation of subunit vaccines. Bachrach HL J Am Vet Med Assoc; 1982 Nov; 181(10):992-9. PubMed ID: 6129235 [TBL] [Abstract][Full Text] [Related]
19. Vaccination of cattle with bovine papillomavirus type 4 L2 elicits the production of virus-neutralizing antibodies. Gaukroger JM; Chandrachud LM; O'Neil BW; Grindlay GJ; Knowles G; Campo MS J Gen Virol; 1996 Jul; 77 ( Pt 7)():1577-83. PubMed ID: 8758002 [TBL] [Abstract][Full Text] [Related]
20. Protection of cattle and swine against foot-and-mouth disease, using biosynthetic peptide vaccines. Morgan DO; Moore DM Am J Vet Res; 1990 Jan; 51(1):40-5. PubMed ID: 2154148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]